Sabra Healthcare REIT (NASDAQ:SBRA) CEO Sells $4,166,000.00 in Stock

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) CEO Richard Matros sold 200,000 shares of the business’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Sabra Healthcare REIT Price Performance

Shares of SBRA traded down $0.02 during trading hours on Wednesday, reaching $20.79. 3,332,324 shares of the company traded hands, compared to its average volume of 1,900,442. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $5.31 billion, a PE ratio of 79.96, a price-to-earnings-growth ratio of 1.58 and a beta of 0.65. Sabra Healthcare REIT, Inc. has a fifty-two week low of $17.17 and a fifty-two week high of $22.77. The stock has a fifty day simple moving average of $20.68 and a 200 day simple moving average of $20.20.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.27). The firm had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The company’s revenue for the quarter was up 24.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.38 EPS. As a group, research analysts predict that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.8%. The ex-dividend date of this dividend was Friday, August 14th. Sabra Healthcare REIT’s payout ratio is currently 461.54%.

Institutional Trading of Sabra Healthcare REIT

Several large investors have recently bought and sold shares of SBRA. Focus Partners Wealth grew its holdings in Sabra Healthcare REIT by 11.4% during the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock valued at $404,000 after purchasing an additional 2,375 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 1,536 shares in the last quarter. First Trust Advisors LP lifted its stake in shares of Sabra Healthcare REIT by 27.2% in the second quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock worth $6,793,000 after acquiring an additional 78,709 shares in the last quarter. Cerity Partners LLC boosted its holdings in Sabra Healthcare REIT by 73.0% in the second quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock valued at $345,000 after purchasing an additional 7,885 shares during the last quarter. Finally, Daiwa Securities Group Inc. grew its stake in Sabra Healthcare REIT by 3.1% during the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock valued at $1,547,000 after purchasing an additional 2,557 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on SBRA shares. UBS Group set a $25.00 target price on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Raymond James Financial raised Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Citizens Jmp boosted their target price on Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a report on Wednesday, July 22nd. Finally, Barclays raised their price target on shares of Sabra Healthcare REIT from $21.00 to $23.00 and gave the company an “equal weight” rating in a report on Monday, August 31st. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $22.17.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.